Phase 2b Study of ALTO-100 in MDD

Condition:   Major Depressive Disorder Interventions:   Drug: ALTO-100;   Drug: Placebo Sponsor:   Alto Neuroscience Recruiting

Source: ClinicalTrials.gov - February 3, 2023 Category: Research Source Type: clinical trials